EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis

Jerney de Jongh, Sam Groothuizen, Gerben J C Zwezerijnen, Robert Hemke, Tom Doorschodt, Ralph Paul Maguire, Tom Vaux, Conny J van der Laken

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 7811-7819

DOI: 10.1007/s00259-026-08178-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 09.10.2026. Verfasst von Jerney de Jongh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorine Radioisotopes, Axial Spondyloarthritis, Sodium Fluoride. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate longitudinal changes of Na[ 18 F]Fluoride uptake in the axial skeleton of patients with radiographic axial spondyloarthritis (r-axSpA) during biological treatment, focusing on r-axSpA and degenerative (D) lesions.

Methods

20 active r-axSpA patients were included. Na[ 18 F]Fluoride Positron Emission Tomography / Computed Tomography (PET/CT) scans were performed prior to, as well as 12 and 52 weeks after starting biological therapy. PET-positive lesions in the axial skeleton were scored and classified by two blinded readers. Quantitative Na[ 18 F]Fluoride uptake was assessed by determination of standardized uptake values (SUV) corrected for individual integrated whole blood activity concentration (SUV AUC ).

Results

A total of 276 lesions with visual Na[ 18 F]Fluoride uptake were detected, of which 98 (36%) were defined as r-axSpA and 46 (17%) as D. The total number of r-axSpA lesions decreased from 98 at baseline to 67 at week 12 (-32%) and to 55 at week 52 (-18%), while the number of D lesions remained stable over time. The majority of r-axSpA lesions were observed in the thoracic spine (84%), while the majority of D lesions were observed in the lumbar spine (48%). Quantitatively, 84% and 88% of the r-axSpA lesions showed a decrease of Na[ 18 F]Fluoride uptake between baseline and 12 and 52 weeks, respectively. In contrast, most D lesions either showed an increase or mild decrease between baseline and follow-up.

Conclusion

Na[ 18 F]Fluoride uptake in visually classified r-axSpA and D lesions in r-axSpA patients on PET/CT demonstrated a striking different change in both the number of r-axSpA lesions and quantitative tracer uptake herein versus D lesions while on biological treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorine RadioisotopesAxial SpondyloarthritisSodium FluorideHumansFemaleLongitudinal StudiesMaleAdultMiddle AgedDiagnosis, Differential

Stichwörter der Autor:innen

Ankylosing spondylitisImagingNa[18F]FluoridePositron emission tomographyRadiographic axial spondyloarthritis

Substanzen

Fluorine RadioisotopesFluorine-18Sodium Fluoride

Autor:innen und Institutionen

  • Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands. s.groothuizen@amsterdamumc.nl.
  • Department of Radiology & Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Radiology & Nuclear Medicine, OLVG, Amsterdam, The Netherlands.
  • UCB Biopharma SRL, Brussels, Belgium.
  • UCB Pharma, Slough, United Kingdom.

Förderung

  • UCB Pharma

Zitieren

APA

de Jongh, J., Groothuizen, S., Zwezerijnen, G. J. C., Hemke, R., Doorschodt, T., Maguire, R. P., Vaux, T., & van der Laken, C. J. (2026). Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 7811-7819. https://doi.org/10.1007/s00259-026-08178-6

Vancouver

de Jongh J, Groothuizen S, Zwezerijnen GJC, Hemke R, Doorschodt T, Maguire RP, et al. Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):7811-7819. doi:10.1007/s00259-026-08178-6

BibTeX
@article{deJongh2026,
  author = {de Jongh, Jerney and Groothuizen, Sam and Zwezerijnen, Gerben J C and Hemke, Robert and Doorschodt, Tom and Maguire, Ralph Paul and Vaux, Tom and van der Laken, Conny J},
  title = {Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {7811--7819},
  doi = {10.1007/s00259-026-08178-6}
}
Kostenlos starten →